Euroasian Journal of Hepato-Gastroenterology

Register      Login

VOLUME 6 , ISSUE 1 ( January-June, 2016 ) > List of Articles

LETTERS TO EDITOR

Interstitial Pneumonitis Related to Pegylated Interferon Alfa-2a Treatment in a Patient with Chronic Hepatitis C

Erhan Alkan, Mete Akin, Haydar Adanir, Yasar Tuna

Citation Information : Alkan E, Akin M, Adanir H, Tuna Y. Interstitial Pneumonitis Related to Pegylated Interferon Alfa-2a Treatment in a Patient with Chronic Hepatitis C. Euroasian J Hepatogastroenterol 2016; 6 (1):91-92.

DOI: 10.5005/jp-journals-10018-1176

License: CC BY-NC 4.0

Published Online: 01-01-2016


Abstract


PDF Share
  1. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002 Nov;36(5 Suppl 1):S237-S244
  2. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C. Am J Gastroenterol 2002 Sep;97(9):2432-2440
  3. Spectrum of pulmonary Toxicity associated with use of interferon therapy for hepatitis C. Case report and review of literature. Clin Infect Dis 2004 Dec;39(11):1724-1729
  4. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996 Sep;25(3):283-291
  5. Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature. Dig Dis Sci 2010 Mar;55(3):579-585
  6. Interstitial pneumonitis associated with pegylated interpheron- alfa 2a and ribavirin for chronic hepatitis C virus infection: a case report. Cases J 2009 Mar 10;2:6464
  7. Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis. Eur Respir J 1996 Dec;9(12):2691-2696
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.